Xolair vs Advair Diskus
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| US Xolair | US Advair Diskus | |
|---|---|---|
| Generic name | omalizumab | fluticasone/salmeterol |
| Drug class | Anti-IgE Monoclonal Antibody | Inhaled Corticosteroid / LABA Combination |
| Treats | Allergic asthma, chronic hives, food allergy | Asthma and COPD |
| Category | Respiratory | Respiratory |
| Manufacturer | Genentech/Novartis | GSK |
| Year approved | 2003 | 2000 |
| FDA warning | Black box warning | Moderate warnings |
| Est. TV ad spend | $95M | — |
| Common side effects | Anaphylaxis (severe allergic reaction), Injection site reactions, Joint pain, Headache | Thrush (mouth infection), Hoarse voice, Headache, Throat irritation |
Advair Diskus
Frequently asked questions
Is Xolair or Advair Diskus better?
Neither is universally "better." Xolair (omalizumab) and Advair Diskus (fluticasone/salmeterol) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Xolair and Advair Diskus?
Xolair is a Anti-IgE Monoclonal Antibody made by Genentech/Novartis, while Advair Diskus is a Inhaled Corticosteroid / LABA Combination made by GSK. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Xolair has the larger estimated TV advertising budget of the two.